Pathogenesis of venous thromboembolism: When the cup runneth over

Seminars in Thrombosis and Hemostasis

Volumn 34, Issue 8, 2008, Pages 747-761

  Lippi, Giuseppe ^a,c   Franchini, Massimo ^b  

^a UNIVERSITY OF VERONA   (Italy)

^b UNIVERSITY HOSPITAL OF PARMA   (Italy)

^c UNIVERSITY HOSPITAL OF VERONA   (Italy)

Author keywords

Pathogenesis; Pulmonary embolism; Risk factor; Thrombosis; Venous thrombosis

Indexed keywords

ANTITHROMBIN III; BLOOD CLOTTING FACTOR 5 LEIDEN; DESOGESTREL; ESTROGEN; ETHINYLESTRADIOL PLUS LEVONORGESTREL; ETHINYLESTRADIOL PLUS NORETHISTERONE; GESTODENE; LEVONORGESTREL; PHOSPHOLIPID ANTIBODY; PLASMINOGEN; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEIN C; PROTEIN S; RALOXIFENE; TAMOXIFEN; TISSUE PLASMINOGEN ACTIVATOR;

AGING; ANTITHROMBIN DEFICIENCY; BLOOD CLOTTING; BLOOD COMPONENT; BLOOD FLOW; BLOOD VESSEL WALL; BRAIN CANCER; BREAST CANCER; CARDIOVASCULAR RISK; COLON CANCER; CONGENITAL BLOOD VESSEL MALFORMATION; CONGESTIVE HEART FAILURE; DIABETES MELLITUS; HEAD AND NECK CANCER; HORMONE SUBSTITUTION; HOSPITAL CARE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERCOAGULABILITY; HYPERTENSION; INHERITANCE; INJURY; ISCHEMIA; KIDNEY CANCER; LEUKEMIA; LIVER CANCER; LOW DRUG DOSE; LUNG CANCER; LYMPHOMA; MENOPAUSAL SYNDROME; MUSCLE CONTRACTION; OBESITY; ORAL CONTRACEPTION; OSTEOPOROSIS; OVARY CANCER; PANCREAS CANCER; PARALYSIS; PATHOGENESIS; PREGNANCY; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN C DEFICIENCY; PROTEIN S DEFICIENCY; PUERPERIUM; RECTUM CANCER; REVIEW; RISK FACTOR; SMOKING; STOMACH CANCER; STROKE; SURGICAL INJURY; THROMBOPHILIA; UTERUS CANCER; VARICOSIS; VENOUS THROMBOEMBOLISM;

HUMANS; VENOUS THROMBOEMBOLISM;

EID: 60549086610     PISSN: 00946176     EISSN: 10989064     Source Type: Journal    
DOI: 10.1055/s-0029-1145257     Document Type: Review

References (117)

1. van Rossum AB, van Houwelingen HC, Kieft GJ, Pattynama PM. Prevalence of deep vein thrombosis in suspected and proven pulmonary embolism: a meta-analysis. Br J Radiol 1998;71:1260-1265
2. Girard P, Musset D, Parent F, Maitre S, Phlippoteau C, Simonneau G. High prevalence of detectable deep venous thrombosis in patients with acute pulmonary embolism. Chest 1999;116:903-908
3. Girard P, Sanchez O, Leroyer C, et al. Evaulation du Scanner Spiralé dans l'Embolie Pulmonaire Study Group. Deep venous thrombosis in patients with acute pulmonary embolism: prevalence, risk factors, and clinical significance. Chest 2005;128:1593-1600
4. Cushman M. Epidemiology and risk factors for venous thrombosis. Semin Hematol 2007;44:62-69
5. Ageno W, Squizzato A, Garcia D, Imberti D. Epidemiology and risk factors of venous thromboembolism. Semin Thromb Hemost 2006;32:651-658
6. Virchow R. Phlogose und Thrombose im Gefäßsystem; Gesammelte Abhandlungen zur Wissenschaftlichen Medizin. Frankfurt, Germany: Staatsdruckerei; 1856
7. Mammen EF. Pathogenesis of venous thrombosis. Chest 1992;102(6, Suppl):640S-644S
8. Spencer F, Becker RC. Diagnosis and management of inherited and acquired thrombophilias. J Thromb Thrombolysis 1999;7:91-104
9. Mammen EF. Antithrombin: its physiological importance and role in DIC. Semin Thromb Hemost 1998;24:19-25
10. Mammen EF. Clinical relevance of antithrombin deficiencies. Semin Hematol 1995;32(4, Suppl 2):2-6
11. Seligsohn U, Lubetsky A. Genetic susceptibility to venous thrombosis. N Engl J Med 2001;344:1222-1231
12. Buchanan GS, Rodgers GM, Branch DW. The inherited thrombophilias: genetics, epidemiology, and laboratory evaluation. Best Pract Res Clin Obstet Gynaecol 2003;17: 397-411
13. Crowther MA, Kelton JG. Congenital thrombophilic states associated with venous thrombosis: a qualitative overview and proposal classification system. Ann Intern Med 2003;138:128-134
14. Mammen EF, Thomas WR, Seegers WH. Activation of purified prothrombin to autoprothrombin I or autoprothrombin II (platelet cofactor II or autoprothrombin II-A). Thromb Diath Haemorrh 1960;5:218-249
15. Simioni P. The molecular genetics of familial venous thrombosis. Baillieres Best Pract Res Clin Haematol 1999;12:479-503
16. Griffin JH, Evatt B, Zimmerman TS, et al. Deficiency of protein C in congenital thrombotic disease. J Clin Invest 1981;68:1370-1373
17. De Stefano V, Finazzi G, Mannucci PM. Inherited thrombophilia: pathogenesis, clinical syndromes and management. Blood 1996;87:3531-3544
18. Franco RF, Reitsma PH. Genetic risk factors of venous thrombosis. Hum Genet 2001;109:369-384
19. Borgel D, Gandrille S, Aiach M. Protein S deficiency. Thromb Haemost 1997;78:351-356
20. Comp PC, Esmon CT. Recurrent venous thromboembolism in patients with a partial deficiency of protein S. N Engl J Med 1984;311:1525-1528
21. Gandrille S, Borgel D, Ireland H, et al. Protein S deficiency: a database of mutations. For the Plasma Coagulation Inhibitors Subcommittee of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. Thromb Haemost 1997;77:1201-1214
22. Dahlback B, Hildebrand B. Inherited resistance to activated protein C is corrected by anticoagulant cofactor activity found to be a property of factor V. Proc Natl Acad Sci U S A 1994;91:1396-1400
23. Bertina RM, Koeleman BP, Koster T, et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994;369:64-67
24. Williamson D, Brown K, Luddington R, Baglin C, Baglin T, Factor V. Cambridge: a new mutation (Arg306!Thr) associated with resistance to activated protein C. Blood 1998;91:1140-1144
25. Bernardi F, Faioni EM, Castoldi E, et al. A factor V genetic component differing from factor V R506Q contributes to the activated protein C resistance phenotype. Blood 1997;90:1552-1557
26. Chan WP, Lee CK, Kwong YL, Lam CK, Liang R. A novel mutation of Arg306 of factor V gene in Hong Kong Chinese. Blood 1998;91:1135-1139
27. Rees DC, Cox M, Clegg JB. World distribution of factor V Leiden. Lancet 1995;346:1133-1134
28. Rosendaal FR, Koster T, Vandenbroucke JP, Reitsma PH. High risk of thrombosis in patients homozygous for factor V Leiden. Blood 1995;85:1504-1508
29. Cushman M, Tsai AW, White RH, et al. Deep vein thrombosis and pulmonary embolism in two cohorts: The Longitudinal Investigation of Thromboembolism Etiology. Am J Med 2004;117:19-25
30. Poort SR, Rosendaal FR, Reitsma PH, Bertina RM. A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 1996;88:3698-3703
31. Rosendaal FR, Doggen CJ, Zivelin A, et al. Geographic distribution of the 20210 G to A prothrombin variant. Thromb Haemost 1998;79:706-708
32. Margaglione M, Brancaccio V, De Lucia D, et al. Inherited thrombophilic risk factors and venous thromboembolism: distinct role in peripheral deep venous thrombosis and pulmonary embolism. Chest 2000;118:1405-1411
33. Mammen EF. Sticky platelet syndrome. Semin Thromb Hemost 1999;25:361-365
34. Frenkel EP, Mammen EF. Sticky platelet syndrome and thrombocythemia. Hematol Oncol Clin North Am 2003;17:63-83
35. Weber M, Gerdsen F, Gutensohn K, Schoder V, Eifrig B, Hossfeld DK. Enhanced platelet aggregation with TRAP-6 and collagen in platelet aggregometry in patients with venous thromboembolism. Thromb Res 2002;107:325-328
36. Clagett GP, Reisch JS. Prevention of venous thromboembolism in general surgical patients: results of meta-analysis. Ann Surg 1988;208:227-240
37. Rosendaal FR. Venous thrombosis: the role of genes, environment, and behavior. Hematology (Am Soc Hematol Educ Program) 2005:1-12
38. Bergqvist D. Venous thromboembolism: a review of risk and prevention in colorectal surgery patients. Dis Colon Rectum 2006;49:1620-1628
39. Most D, Kozlow J, Heller J, Shermak M. Thromboembolism in plastic surgery. Plast Reconstr Surg 2005;115:20e-30e
40. Rohrich RJ, Rios JL. Venous thromboembolism in cosmetic plastic surgery. Plast Reconstr Surg 2003;112:871-872
41. Hughes CE. Reduction of lipoplasty risks and mortality. Aesth Surg 2001;21:161-163
42. Bannink L, Doggen CJM, Nelissen RGHH, Rosendaal FR. Increased risk of venous thrombosis after orthopedic and general surgery: results of the MEGA study [abstract]. J Thromb Haemost 2005;3(Suppl 1):1653
43. White RH, Zhou H, Romano PS. Incidence of symptomatic venous thromboembolism after different elective or urgent surgical procedures. Thromb Haemost 2003;90:446-455
44. Pineo GF, Hull RD. Prophylaxis of venous thromboembolism following orthopaedic surgery: mechanical and pharmacological approaches and the need for extended prophylaxis. Thromb Haemost 1999;82:918-924
45. Ilahi OA, Reddy J, Ahmad I. Deep venous thrombosis after knee arthroscopy: a meta-analysis. Arthroscopy 2005;21:727-730
46. van Stralen KJ, Rosendaal FR, Doggen CJ. Minor injuries as a risk factor for venous thrombosis. Arch Intern Med 2008;168:21-26
47. Piccioli A, Falanga A, Baccaglini U, Marchetti M, Prandoni P. Cancer and venous thromboembolism. Semin Thromb Hemost 2006;32:694-699
48. Franchini M, Montagnana M, Targher G, Manzato F, Lippi G. Pathogenesis, clinical and laboratory aspects of thrombosis in cancer. J Thromb Thrombolysis 2007;24:29-38
49. Trousseau A. Phlegmasia alba dolens. In: Clinique Médicale de l'Hôtel-Dieu de Paris. Paris: Ballière; 1865:654-712
50. Bergqvist D. Venous thromboembolism in cancer patients: expanding horizons. Semin Thromb Hemost 2002;28(Suppl 3):19-23
51. Agnelli G. Venous thromboembolism and cancer: a two way clinical association. Thromb Haemost 1997;78:117-120
52. Sorensen HT, Mellemkjaer L, Olsen JH, Baron JA. Prognosis of cancers associated with venous thromboembolism. N Engl J Med 2000;343:1846-1850
53. Heit JA. Cancer and venous thromboembolism: scope of the problem. Cancer Control 2005;12(Suppl 1):5-10
54. Hutten BA, Prins MH, Gent M, Ginsberg J, Tijssen JG, Buller HR. Incidence of recurrent thromboembolic and bleeding complications among patients with venous thromboembolism in relation to both malignancy and achieved international normalized ratio: a retrospective analysis. J Clin Oncol 2000;18:3078-3083
55. Prandoni P, Lensing AWA, Piccioli A, et al. Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis. Blood 2002;100:3484-3488
56. Blom JW, Doggen CJM, Osanto S, Rosendaal FR. Malignancies, prothrombotic mutations, and the risk of venous thrombosis. JAMA 2005;293:715-722
57. Heit JA, Silverstein MD, Mohr DN, Petterson TM, O'Fallon WM, Melton LJ III. Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study. Arch Intern Med 2000;160:809-815
58. Silverstein MD, Heit JA, Mohr DN, Petterson TM, O'Fallon WM, Melton LJ III. Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study. Arch Intern Med 1998;158:585-593
59. Sutherland DE, Weitz IC, Liebman HA. Thromboembolic complications of cancer: epidemiology, pathogenesis, diagnosis, and treatment. Am J Hematol 2003;72:43-52
60. Levitan N, Dowlati A, Remick SC, et al. Rates of initial and recurrent thromboembolic disease among patients with malignancy versus those without malignancy. Risk analysis using Medicare claims data. Medicine (Baltimore) 1999;78:285-291
61. Thodiyil PA, Kakkar AK. Variation in relative risk of venous thromboembolism in different cancers. Thromb Haemost 2002;87:1076-1077
62. Lee AY, Levine MN. The thrombophilic state induced by therapeutic agents in the cancer patient. Semin Thromb Hemost 1999;25:137-145
63. Bick RL. Cancer-associated thrombosis. N Engl J Med 2003;349:109-110
64. Fisher B, Costantino J, Redmond C, et al. A randomized clinical trial evaluating tamoxifen in the treatment of patients with node-negative breast cancer who have estrogen-receptor-positive tumors. N Engl J Med 1989;320:479-484
65. Pritchard KI, Paterson AH, Paul NA, et al. Increased thromboembolic complications with concurrent tamoxifen and chemotherapy in a randomized trial of adjuvant therapy for women with breast cancer. National Cancer Institute of Canada Clinical Trials Group Breast Cancer Site Group. J Clin Oncol 1996;14:2731-2737
66. Freytes CO. Thromboembolic complications related to central venous access catheters in cancer patients. Semin Thromb Hemost 2007;33:389-396
67. Piazza G, Seddighzadeh A, Goldhaber SZ. Double trouble for 2,609 hospitalized medical patients who developed deep vein thrombosis: prophylaxis omitted more often and pulmonary embolism more frequent. Chest 2007;132:554-561
68. Cohen AT, Tapson VF, Bergmann JF, et al. ENDORSE Investigators. Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study. Lancet 2008;371:387-394
69. Le Jeune S, Pistorius MA, Planchon B, Pottier P. Risk of venous thromboembolism in acute medical illnesses. Part 2: situations at risk in ambulatory, hospital and internal medicine settings. Rev Med Interne 2008;29:462-475
70. Gallus AS. Travel, venous thromboembolism, and thrombophilia. Semin Thromb Hemost 2005;31:90-96
71. Ettema HB, Kollen BJ, Verheyen CC, Büller HR. Prevention of venous thromboembolism in patients with immobilization of the lower extremities: a meta-analysis of randomized controlled trials. J Thromb Haemost 2008;6:1093-1098
72. Simpson K. Shelter deaths from pulmonary embolism. Lancet 1940;ii:744
73. Homans J. Thrombosis of the deep leg veins due to prolonged sitting. N Engl J Med 1954;250:148-149
74. Cruickshank JM, Gorlin R. Air travel and thrombotic episodes: the economy class syndrome. Lancet 1988;2:497-498
75. Kuipers S, Schreijer AJ, Cannegieter SC, Büller HR, Rosendaal FR, Middeldorp S. Travel and venous thrombosis: a systematic review. J Intern Med 2007;262:615-634
76. Ten Wolde M, Kraaijenhagen RA, Schiereck J, et al. Travel and the risk of symptomatic venous thromboembolism. Thromb Haemost 2003;89:499-505
77. United Nations Population Division. World Contraceptive Use 2001. New York, NY: United Nations; 2002
78. Watson HG. Sex hormones and thrombosis. Semin Hematol 2007;44:98-105
79. Royal College of Obstetricians and Gynaecologists (RCOG). Venous Thromboembolism and Hormonal Contraception. Guideline no. 40. London, United Kingdom: Royal College of Obstetricians and Gynaecologists; 2004
80. Gomes MP, Deitcher SR. Risk of venous thromboembolic disease associated with hormonal contraceptives and hormone replacement therapy: a clinical review. Arch Intern Med 2004;164:1965-1976
81. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. Venous thromboembolic disease and combined oral contraceptives: results of international multicentre case-control study. Lancet 1995;346:1575-1582
82. Jick H, Jick SS, Gurewich V, Myers MW, Vasilakis C. Risk of idiopathic cardiovascular death and nonfatal venous thromboembolism in women using oral contraceptives with differing progestagen components. Lancet 1995;346:1589-1593
83. Bloemenkamp KW, Rosendaal FR, Helmerhorst FM, Buller HR, Vandenbroucke JP. Enhancement by factor V Leiden mutation of risk of deep-vein thrombosis associated with oral contraceptives containing a third-generation progestagen. Lancet 1995;346:1593-1596
84. Spitzer WO, Lewis MA, Heinemann LA, Thorogood M, MacRae KD. Third generation oral contraceptives and risk of venous thromboembolic disorders: an international case-control study. BMJ 1996;312:83-88
85. Farley TM, Meirik O, Collins J. Cardiovascular disease and combined oral contraceptives: reviewing the evidence and balancing the risks. Hum Reprod Update 1999;5:721-735
86. Kemmeren JM, Algra A, Grobbee DE. Third generation oral contraceptives and risk of venous thrombosis: meta-analysis. BMJ 2001;323:131-134
87. Mammen EF. Oral contraceptive pills and hormonal replacement therapy and thromboembolic disease. Hematol Oncol Clin North Am 2000;14:1045-1059
88. Simioni P, Sanson BJ, Prandoni P, et al. Incidence of venous thromboembolism in families with inherited thrombophilia. Thromb Haemost 1999;81:198-202
89. Lippi G, Manzato F, Brocco G, Franchini M, Guidi G. Prothrombotic effects and clinical implications of third-generation oral contraceptives use. Blood Coagul Fibrinolysis 2002;13:69-72
90. Tan JY. Thrombophilia in pregnancy. Ann Acad Med Singapore 2002;31:328-334
91. McColl MD, Ramsay JE, Tait RC, et al. Risk factors for pregnancy associated venous thromboembolism. Thromb Haemost 1997;78:1183-1188
92. Bates SM, Greer IA, Pabinger I, Sofaer S, Hirsh J. Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008;133:844S-886S
93. Pomp ER, Lenselink AM, Rosendaal FR, Doggen CJ. Pregnancy, the postpartum period and prothrombotic defects: risk of venous thrombosis in the MEGA study. J Thromb Haemost 2008;6:632-637
94. Ros HS, Lichtenstein P, Bellocco R, et al. Pulmonary embolism and stroke in relation to pregnancy: how can high-risk women be identified? Am J Obstet Gynecol 2002;186:198-203
95. Martinelli I, De Stefano V, Taioli E, Paciaroni K, Rossi E, Mannucci PM. Inherited thrombophilia and first venous thromboembolism during pregnancy and puerperium. Thromb Haemost 2002;87:791-795
96. Gerhardt A, Scharf RE, Beckmann MW, et al. Prothrombin and factor V mutations in women with a history of thrombosis during pregnancy and the puerperium. N Engl J Med 2000;342:374-380
97. Gerhardt A, Scharf RE, Zotz RB. Effect of hemostatic risk factors on the individual probability of thrombosis during pregnancy and the puerperium. Thromb Haemost 2003;90:77-85
98. Gammaro L, Lippi G, Bottini E, et al. Severe preeclampsia in antithrombin III deficiency with no history of venous thromboembolism. J Nephrol 2001;14:312-315
99. Brenner B. Thrombophilia and fetal loss. Semin Thromb Hemost 2003;29:165-170
100. Rodger MA, Paidas M. Do thrombophilias cause placenta-mediated pregnancy complications? Semin Thromb Hemost 2007;33:597-603
101. Gerbasi FR, Bottoms S, Farag A, Mammen EF. Changes in hemostasis activity during delivery and the immediate postpartum period. Am J Obstet Gynecol 1990;162:1158-1163
102. Hickey M, Davis SR, Sturdee DW. Treatment of menopausal symptoms: what shall we do now? Lancet 2005;366:409-421
103. Nippita TA, Baber RJ. Premature ovarian failure: a review. Climacteric 2007;10:11-22
104. Sare GM, Gray LJ, Bath PM. Association between hormone replacement therapy and subsequent arterial and venous vascular events: a meta-analysis. Eur Heart J 2008;29:2031-2041
105. Adomaityte J, Farooq M, Qayyum R. Effect of raloxifene therapy on venous thromboembolism in postmenopausal women. A meta-analysis. Thromb Haemost 2008;99:338-342
106. Canonico M, Plu-Bureau G, Lowe GD, Scarabin PY. Hormone replacement therapy and risk of venous thromboembolism in postmenopausal women: systematic review and meta-analysis. BMJ 2008;336:1227-1231
107. Samama MM. An epidemiologic study of risk factors for deep vein thrombosis in medical outpatients: the Sirius study. Arch Intern Med 2000;160:3415-3420
108. White HR, Gettner S, Newman J, Trauner KB, Romano SP. Predictors of rehospitalization for symptomatic venous thromboembolismafter total hip arthroplasty. N Engl J Med 2000;343:1758-1764
109. Abdollahi M, Cushman M, Rosendaal FR. Obesity: risk of venous thrombosis and the interaction with coagulation factor levels and oral contraceptive use. Thromb Haemost 2003;89:493-498
110. Ageno W, Becattini C, Brighton T, Selby R, Kamphuisen PW. Cardiovascular risk factors and venous thromboembolism: a meta-analysis. Circulation 2008;117:93-102
111. Bick RL, Baker WF. Antiphospholipid syndrome and thrombosis. Semin Thromb Hemost 1999;25:333-350
112. Wahl DG, Guillemin F, de Maistre E, Perret-Guillaume C, Lecompte T, Thibaut G. Meta-analysis of the risk of venous thrombosis in individuals with antiphospholipid antibodies without underlying autoimmune disease or previous thrombosis. Lupus 1998;7:15-22
113. Galli M, Barbui T. Antiphospholipid syndrome: clinical and diagnostic utility of laboratory tests. Semin Thromb Hem ost 2005;31:17-24
114. Sofi F, Marcucci R, Abbate R, Gensini GF, Prisco D. Lipoprotein (a) and venous thromboembolism in adults: a meta-analysis. Am J Med 2007;120:728-733
115. den Heijer M, Rosendaal FR, Blom HJ, Gerrits WB, Bos GM. Hyperhomocysteinemia and venous thrombosis: a meta-analysis. Thromb Haemost 1998;80:874-877
116. Cattaneo M. Hyperhomocysteinemia and venous thromboembolism. Semin Thromb Hemost 2006;32:716-723
117. Simioni P, Sanson BJ, Prandoni P, et al. Incidence of venous thromboembolism in families with inherited thrombophilia. Thromb Haemost 1999;81:198-202